Barramundi Group [Euronext Growth Oslo: BARRA] will present the YTD September 2022 business update to investors, analysts and media on Tuesday 29th November 2022 at 09:00 CET / 16:00 SGT. The online presentation will be followed by a Q&A session. Both will be hosted by the Company’s CEO Andreas von Scholten.
The YTD September 2022 business update will be published on the Euronext Newsweb and the company’s website on Tuesday 29th November 2022 at 08:00 CET / 15:00 SGT.
Register in advance for the webinar:
https://us02web.zoom.us/webinar/register/WN_p_rb7v8ARlSF7wiMLR2UTA
After registering, you will receive a confirmation email containing information about joining the webinar.
For media and investor inquiries, please contact:
Andreas von Scholten Chief Executive Officer Barramundi Group Telephone: +65 6261 0010 Email: investors@barramundi.com
Helen Chow Chief Financial Officer Barramundi Group Telephone: +65 6261 0010 Email: investors@barramundi.com
Company investor centre
https://barramundi.com/investors
About Barramundi Group
Barramundi Group brings great-tasting premium quality fish to the world, with sustainability at our core. The Group’s mission is to help close the world’s protein gap by tapping into the potential of barramundi. Through their pioneering, world-class research and technology, their sustainable best practices enables them to produce responsibly-farmed barramundi while safeguarding the world’s oceans and environmental resources.
As one of the largest barramundi producers in Asia Pacific, Barramundi Group operates through a unique end-to-end aquaculture model, with comprehensive in-house capabilities ranging from vaccine development, end-product innovation and processing, to hatchery facilities.
The Group also boasts a robust commercial reach across key markets including Singapore, Australia, China, Hong Kong, South Korea, and the U.S. Barramundi Group’s future growth plan looks to tap into the growing global demand for barramundi and the overall consumer trend towards sustainable consumption, which is projected to increase exponentially over the next five years.